Skip to content
Peptilyze
Growth hormone axis

Ipamorelin studies

54 journal papers mention Ipamorelin in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Ipamorelin is safe, effective or approved for any use.

Compare Ipamorelin prices, from €15.06 →

Papers
54
48 articles, 6 reviews
Earliest paper
1998
Most papers in 1998 (11)
Open access
31%
free to read somewhere
Reviews
11%
of all papers listed

What kind of studies

Of 51 papers in PubMed that mention Ipamorelin in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials2
  • Other clinical trials0
  • Meta-analyses and systematic reviews0
  • Other reviews10
  • Case reports0
  • Animal studies only20
  • Studies in humans25

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Registered clinical studies

Studies on ClinicalTrials.gov that mention Ipamorelin in their intervention details. A registration says a study is planned or running, not what it found.

Registered
3
Completed
2
Ongoing or planned
1
Phase 1
0
Phase 2
2
Phase 3
0
  1. Trifecta Research Study

    NCT07717866Active, not recruitingstarted 2022-08-01

  2. Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

    NCT00672074CompletedPhase 2started 2008-04

  3. Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

    NCT01280344CompletedPhase 2started 2011-04

The five most recently updated studies. See all 3 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.

Papers per year

1998 to 2026, peak 11 papers in a year. The latest year may still be incomplete.

1998: 11 papers1999: 6 papers2000: 1 papers2001: 4 papers2002: 1 papers2003: 1 papers2004: 1 papers2005: 0 papers2006: 1 papers2007: 0 papers2008: 0 papers2009: 3 papers2010: 0 papers2011: 6 papers2012: 1 papers2013: 0 papers2014: 1 papers2015: 0 papers2016: 0 papers2017: 0 papers2018: 2 papers2019: 0 papers2020: 2 papers2021: 0 papers2022: 0 papers2023: 0 papers2024: 2 papers2025: 2 papers2026: 9 papers19982026

Where it is published

  1. Growth Hormone & IGF Research8 papers
  2. Gastroenterology7 papers
  3. European Journal of Medicinal Chemistry4 papers
  4. The American Journal of Sports Medicine2 papers
  5. The Journal of Sexual Medicine2 papers

The papers

Most citedName in the title

  1. Ipamorelin, the first selective growth hormone secretagogue

    Kirsten Raun, Birgit Sehested Hansen, N. Johansen et al. · European Journal of Endocrinology · 1998

    Animal study99 citations

  2. Efficacy of Ipamorelin, a Novel Ghrelin Mimetic, in a Rodent Model of Postoperative Ileus

    Kalina M. Venkova, William Mann, Richard Nelson et al. · Journal of Pharmacology and Experimental Therapeutics · 2009

    Animal study34 citations

  3. A New Series of Highly Potent Growth Hormone-Releasing Peptides Derived from Ipamorelin

    Michael Ankersen, Nils Langeland Johansen, Kjeld Madsen et al. · Journal of Medicinal Chemistry · 1998

    Animal study33 citations

  4. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats

    Johan Svensson, Sabrina Lall, Suzanne L. Dickson et al. · Journal of Endocrinology · 2000

    Animal studyOpen access29 citationsRead the open copy →

  5. Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers

    Jogarao V. S. Gobburu, Henrik Agersø, William J. Jusko et al. · Pharmaceutical Research · 1999

    Randomized trial28 citations

  6. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

    On behalf of the Ipamorelin 201 Study Group, David E. Beck, W. Brian Sweeney et al. · International Journal of Colorectal Disease · 2014

    Randomized trial · Phase 227 citations

  7. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats

    Peter B. Johansen, Jette Nowak, Christian Baaner Skjærbæk et al. · Growth Hormone & IGF Research · 1999

    Animal study23 citations

  8. Synthesis and in vitro characterization of new growth hormone secretagogues derived from ipamorelin with dipeptidomimetic N-terminals

    Bernd Peschke, Michael Ankersen, Birgit Sehested Hansen et al. · European Journal of Medicinal Chemistry · 1999

    13 citations

  9. Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin

    Thomas K. Hansen, Michael Ankersen, Kirsten Raun et al. · Bioorganic & Medicinal Chemistry Letters · 2001

    Animal study9 citations

  10. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus

    Beverley Greenwood–Van Meerveld, Karl R. Tyler, Ehsan Mohammadi et al. · Journal of Experimental Pharmacology · 2012

    Open access · CC BY-NC6 citationsRead the open copy →

  11. The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats

    N.B. Andersen, Kjell Malmlöf, P.B. Johansen et al. · Growth Hormone & IGF Research · 2001

    Animal study6 citations

  12. The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus

    Mallikarjun Gouda, C.B. Ganesh · Animal Reproduction Science · 2024

    Animal study4 citations

  13. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption

    P. B. JOHANSEN · Xenobiotica · 1998

    Animal study4 citations

  14. Ipamorelin — A novel very potent growth hormone secretagogue

    MH Rasmussen, B Soogaar, Lars Ynddal et al. · Growth Hormone & IGF Research · 1998

    3 citations

  15. Preclinical Pharmacological Profile of Ipamorelin a Novel Gastroprokinetic for Intestinal Dysmotility

    Claudio Pietra, John Friend, Beverley Greenwood–Van Meerveld · Gastroenterology · 2011

    2 citations

  16. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism

    Zengbing Lu, Man Piu Ngan, Julia Y H Liu et al. · Physiology & Behavior · 2024

    Animal study1 citations

  17. Growth hormone secretagogue ipamorelin reduces the hepatic catabolic stress response during steroid treatment

    Thorbjørn Grøfte, Casper Skjærbæk, Kjell Malmlöf et al. · Growth Hormone & IGF Research · 1998

    1 citations

  18. Growth hormone secretagogue ipamorelin reduces the hepatic catabolic stress response during steroid treatment

    Thorbjørn Grøfte, Casper Skjærbæk, P.B. Johansen et al. · Journal of Hepatology · 1998

    1 citations

  19. Restoring endocrine function in women with premature ovarian insufficiency: A case series on hormonal profile reversal and conception following treatment with Ipamorelin

    Joseph Dib MD, Amal Al-Shunnar, Mouna Fawaz et al. · International Journal of Clinical Obstetrics and Gynaecology · 2026

    Open accessRead the open copy →

  20. In Vitro Effect of Ipamorelin, a Novel Ghrelin Agonist on Gastrointestinal Smooth Muscle Isolated From a Rodent Model of Post-Operative Ileus.

    Ehsan Mohammadi, Karl R. Tyler, Claudio Pietra et al. · Gastroenterology · 2011

  21. 716 Efficacy of Ipamorelin, a Novel Ghrelin Mimetic, in a Rat Model of Postoperative Ileus

    Kalina M. Venkova, William Mann, Richard Nelson et al. · Gastroenterology · 2009

  22. 14 C‐labelling of ipamorelin, a growth hormone secretagogue

    Lars Müller, Kjeld Madsen, Christian Foged · Journal of Labelled Compounds and Radiopharmaceuticals · 1998

  23. 14C‐labelling of ipamorelin, a growth hormone secretagogue

    Lars Müller, Kjeld Madsen, Christian Foged · Journal of Labelled Compounds and Radiopharmaceuticals · 1998

  24. Effects of ipamorelin — A growth hormone secretagogue-on bone formation and skeletal muscle contraction force

    Andersen Nb, Hans Oxlund, Kjell Malmlöf et al. · Growth Hormone & IGF Research · 1998

  25. Pharmacokinetics of ipamorelin, a new GH secretagogue, after iontophoretic and intravenous administration to volunteers

    P Green, Lars Ynddal, Birgitte Søgaard et al. · Growth Hormone & IGF Research · 1998

LatestName in title or abstract

  1. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review

    V Vasylieva, Annette West, Edward Karpman · Sexual Medicine Reviews · 2026

    Review

  2. The peptide boom: a critical appraisal of evidence, patient safety risks, and regulatory failure in the experimental wellness peptide market

    Giorgi Pkhakadze · Georgian Medical Journal · 2026

    Open access · CC BYRead the open copy →

  3. Peptide Supplements and Their Therapeutic Applications in Sports Medicine

    Kushagra Tewari, Timothy P. Liu, Christina Im et al. · The American Journal of Sports Medicine · 2026

    Open access · CC BY1 citationsRead the open copy →

  4. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

    Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026

    ReviewOpen access · CC BY1 citationsRead the open copy →

  5. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging

    Volodymyr Mavrych, Inna Shypilova, Olena Bolgova · Frontiers in Aging · 2026

    ReviewOpen access · CC BY5 citationsRead the open copy →

  6. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    Omar F. Rahman, Steven J. Lee, William A. Seeds · JAAOS Global Research and Reviews · 2026

    ReviewOpen access · CC BY-NC-ND5 citationsRead the open copy →

  7. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

    Cory K. Mayfield, Ioanna K. Bolia, Cailan L Feingold et al. · The American Journal of Sports Medicine · 2026

    Review12 citations

  8. Restoring endocrine function in women with premature ovarian insufficiency: A case series on hormonal profile reversal and conception following treatment with Ipamorelin

    Joseph Dib MD, Amal Al-Shunnar, Mouna Fawaz et al. · International Journal of Clinical Obstetrics and Gynaecology · 2026

    Open accessRead the open copy →

  9. Growth Hormone Secretagogues: Between Endocrine Physiology and the Therapeutic Frontier of GH-IGF-1 Axis-Modulating Peptides

    Pedro Augusto Zaiats, Pedro Henrique Rodrigues Senteio, Diego Ribeiro et al. · Open Journal of Clinical Diagnostics · 2026

    Open access · CC BYRead the open copy →

  10. (197) Peptides in Practice: Evaluating Efficacy and Safety in Men’s Health

    R Arora, Arjun K. Venkatesh, Gene Austin Krishingner et al. · The Journal of Sexual Medicine · 2025

    Open accessRead the open copy →

  11. (349) Therapeutic Peptides in Sexual Medicine: A Narrative Review

    E Burchfiel, N Mills, G Saffati et al. · The Journal of Sexual Medicine · 2025

    ReviewOpen accessRead the open copy →

  12. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism

    Zengbing Lu, Man Piu Ngan, Julia Y H Liu et al. · Physiology & Behavior · 2024

    Animal study1 citations

  13. The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus

    Mallikarjun Gouda, C.B. Ganesh · Animal Reproduction Science · 2024

    Animal study4 citations

  14. Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics

    Ehsan Mohammadi, Tijs Louwies, Claudio Pietra et al. · Journal of Experimental Pharmacology · 2020

    Open access · CC BY-NC3 citationsRead the open copy →

  15. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males

    Deepankar K. Sinha, Adithya Balasubramanian, Alexander J. Tatem et al. · Translational Andrology and Urology · 2020

    ReviewOpen access · CC BY-NC-ND11 citationsRead the open copy →

  16. A stable meta‐carborane enables the generation of boron‐rich peptide agonists targeting the ghrelin receptor

    Dennis J. Worm, Sylvia Els‐Heindl, Martin Kellert et al. · Journal of Peptide Science · 2018

    Study in humans45 citations

  17. Peptidomimetic growth hormone secretagogue derivatives for positron emission tomography imaging of the ghrelin receptor

    Milan M. Fowkes, Tyler J. Lalonde, Lihai Yu et al. · European Journal of Medicinal Chemistry · 2018

    Study in humans11 citations

  18. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

    On behalf of the Ipamorelin 201 Study Group, David E. Beck, W. Brian Sweeney et al. · International Journal of Colorectal Disease · 2014

    Randomized trial · Phase 227 citations

  19. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus

    Beverley Greenwood–Van Meerveld, Karl R. Tyler, Ehsan Mohammadi et al. · Journal of Experimental Pharmacology · 2012

    Open access · CC BY-NC6 citationsRead the open copy →

  20. Does the Prevalence of Fructose and Lactose Intolerance Differ Between ROME III Subgroups of Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS)?

    Clive H. Wilder‐Smith, Andrea Materna · Gastroenterology · 2011

    Open accessRead the open copy →

  21. ROME III Functional Dyspepsia (FD) Criteria: Poor Discrimination Between Postprandial Distress Syndrome (PDS) and Epigastric Pain Syndrome (EPS)

    Nimish B. Vakil, Katarina Halling, Börje Wernersson et al. · Gastroenterology · 2011

    Open access2 citationsRead the open copy →

  22. Preclinical Pharmacological Profile of Ipamorelin a Novel Gastroprokinetic for Intestinal Dysmotility

    Claudio Pietra, John Friend, Beverley Greenwood–Van Meerveld · Gastroenterology · 2011

    2 citations

  23. Regional Analysis of Gastric Emptying Scintigraphy Provides Better Correlation of Dyspeptic Symptoms With Abnormal Gastric Emptying

    Murali Pathikonda, Steven Kantor, Robert S. Fisher et al. · Gastroenterology · 2011

    3 citations

  24. In Vitro Effect of Ipamorelin, a Novel Ghrelin Agonist on Gastrointestinal Smooth Muscle Isolated From a Rodent Model of Post-Operative Ileus.

    Ehsan Mohammadi, Karl R. Tyler, Claudio Pietra et al. · Gastroenterology · 2011

  25. Enteric Dysmotility/ Acquired Chronic Intestinal Pseudo-Obstruction (ED/CIPO) – Relationship Between Small Intestinal Manometric and Neurohistopathological Findings

    Dilshad Chowdhury, Ana H. Raimundo, Ara Wardkes Darzi et al. · Gastroenterology · 2011

  26. 716 Efficacy of Ipamorelin, a Novel Ghrelin Mimetic, in a Rat Model of Postoperative Ileus

    Kalina M. Venkova, William Mann, Richard Nelson et al. · Gastroenterology · 2009

  27. Efficacy of Ipamorelin, a Novel Ghrelin Mimetic, in a Rodent Model of Postoperative Ileus

    Kalina M. Venkova, William Mann, Richard Nelson et al. · Journal of Pharmacology and Experimental Therapeutics · 2009

    Animal study34 citations

  28. Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats

    Niels Kristian Aagaard, Thorbjørn Grøfte, Jacob Raben Greisen et al. · Growth Hormone & IGF Research · 2009

    Animal study4 citations

  29. Seabream ghrelin: cDNA cloning, genomic organization and promoter studies

    Chung-Man Yeung, Chi Bun Chan, Norman Y.S. Woo et al. · Journal of Endocrinology · 2006

    Animal studyOpen access55 citationsRead the open copy →

  30. Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription

    Chi Bun Chan, C.K. Fung, Wendy Fung et al. · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · 2004

    Study in humans16 citations

  31. Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue

    Peter B. Johansen, Yael Segev, Daniel Landau et al. · Journal of Diabetes Research · 2003

    Study in humansOpen access · CC BY10 citationsRead the open copy →

  32. The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency

    Bernd Peschke, Michael Ankersen, Michael W Bauer et al. · European Journal of Medicinal Chemistry · 2002

    Animal study9 citations

  33. The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats

    N.B. Andersen, Kjell Malmlöf, P.B. Johansen et al. · Growth Hormone & IGF Research · 2001

    Animal study6 citations

  34. Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin

    Thomas K. Hansen, Michael Ankersen, Kirsten Raun et al. · Bioorganic & Medicinal Chemistry Letters · 2001

    Animal study9 citations

  35. Do Growth Hormone–Releasing Peptides Act as Ghrelin Secretagogues?

    Ian Ahnfelt-Rønne, Jette Nowak, Uffe Bang Olsen · Endocrine · 2001

    Animal study11 citations

  36. Growth Hormone (GH)-Independent Stimulation of Adiposity by GH Secretagogues

    Sabrina Lall, Loraine Y.C. Tung, Claes Ohlsson et al. · Biochemical and Biophysical Research Communications · 2001

    Animal study88 citations

  37. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats

    Johan Svensson, Sabrina Lall, Suzanne L. Dickson et al. · Journal of Endocrinology · 2000

    Animal studyOpen access29 citationsRead the open copy →

  38. Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats

    Kjell Malmlöf, P.B. Johansen, P-M Haahr et al. · Growth Hormone & IGF Research · 1999

    Animal study8 citations

  39. Demonstration of the strength of focused combinatorial libraries in SAR optimisation of growth hormone secretagogues

    Michael Ankersen · European Journal of Medicinal Chemistry · 1999

    11 citations

  40. Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers

    Jogarao V. S. Gobburu, Henrik Agersø, William J. Jusko et al. · Pharmaceutical Research · 1999

    Randomized trial28 citations

Each list shows up to 40 papers.See all 54 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.